| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd348f97a66b7b5c263168f885f26107 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2020-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30fe171b16896f2c46b67027ee7a3715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca42c0d60d729adb50adac3da9c87ab9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6f0b0e88245bc2c38a873ef69ac717d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_731d06dd0da75de22a437f4346b36b34 |
| publicationDate |
2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11535606-B2 |
| titleOfInvention |
Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof |
| abstract |
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions. In some embodiments, the compounds disclosed herein exhibit androgen receptor degradation activity. |
| priorityDate |
2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |